| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Mukund Prataprai Mehta CEO | XNSE Exchange | Y4776K110 CUSIP |
| India Country | 187 Employees | 20 Sep 2019 Last Dividend | 24 Mar 2026 Last Split | - IPO Date |
Kilitch Drugs (India) Limited, established in 1978 and headquartered in Mumbai, India, is a prominent player in the pharmaceutical industry. The company is dedicated to the development and operation of its pharmaceutical business within India, focusing on the manufacture and distribution of a wide range of pharmaceutical products. Kilitch Drugs is renowned for its extensive portfolio, including parenteral and nasal products, oral formulations, effervescent tablets and powders, nutritional products, a topical skin adhesive, and a variety of cosmetics and herbal products. Besides serving the domestic market, the company has an active presence in the international market through the export of its products.